Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa Enzyme Replacement Therapy Before and After 18 Years of Age

Overview of attention for article published in Drug Design, Development and Therapy, June 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 43 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 2,356 followers.

Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa En… https://t.co/h5uJEmLtT5 #hvhebron #malmin [Text complet]

29 Jun 2020

Reply Repost Favourite

Dove Medical Press

Article Metrics

Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa Enzyme Replacement Therapy Before and After 18 Years of Age

Mentioned by

Citations

Readers on